Aquestive Therapeutics Inc (AQST) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aquestive Therapeutics Inc   (NASDAQ: AQST)


Aquestive Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aquestive Therapeutics Inc's ROI in the second quarter of 2026?
Aquestive Therapeutics Inc recorded a cumulative net loss of $-78 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -65.76%.

Within the Healthcare sector 496 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3199 to 3768.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 43.38 % 18 % 3.25 % 7.43 % 14.56 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 116 109 113 138 71
Return On Investment (TTM) -65.76 % -64 % -82.69 % -73.57 % -78.4 %
AQST's Overall Ranking # 3768 # 3199 # 2713 # 3558 # 3145
Seq. Investment Change TTM 10.47 % 6.28 % 8.07 % 13.01 % -9.09 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -78 -69 -84 -69 -65

AQST Company Profile >> Back to AQST Roi Comparisons >> See Annual AQST Return On Investment



Return On Investment AQST's Ranking
Within: No.
Industry # 216
Sector # 497
Overall # 3768

Return On Investment Statistics
High Average Low
-12.85 %
-107.77 %
-354.6 %
(Dec 31 2023)   (Jun 30 2021)







Financial Statements
Aquestive Therapeutics Inc's II. Quarter Investments $ 116 Millions AQST's Balance sheet
Aquestive Therapeutics Inc's II. Quarter Income $ -23 Millions Quarterly AQST's Income Statement
AQST's Income by Division See AQST's Income by Division


AQST Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 113 83 39 18 40
Y / Y Investment Growth 36.65 % 111.09 % 122.95 % -56.18 % -
Net Income in Millions -84 -44 -8 -54 -71
Y / Y Net Income Growth - - - - -
Annual Return On Investment -74.27 % -53.46 % -20.12 % -310.17 % -176.22 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AQST's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AQST's Competitors
Subscribers only: Roi for Aquestive Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for AQST's Customers

Other Ratios
AQST's Roa AQST's Inventory Turnover Ratio AQST's Growth Rates AQST's Dividend Statistics
AQST's Profitability Ratios AQST's Asset Turnover Ratio AQST's Dividend Growth
AQST's Roe AQST's Valuation Ratios AQST's Financial Strength Ratios AQST's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.